CA2013166A1 - Suppression de la synthese et de la secretion de l'hormone parathyroide - Google Patents

Suppression de la synthese et de la secretion de l'hormone parathyroide

Info

Publication number
CA2013166A1
CA2013166A1 CA2013166A CA2013166A CA2013166A1 CA 2013166 A1 CA2013166 A1 CA 2013166A1 CA 2013166 A CA2013166 A CA 2013166A CA 2013166 A CA2013166 A CA 2013166A CA 2013166 A1 CA2013166 A1 CA 2013166A1
Authority
CA
Canada
Prior art keywords
secretion
suppression
parathyroid hormone
hormone synthesis
hyperparathyroidism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2013166A
Other languages
English (en)
Other versions
CA2013166C (fr
Inventor
Eduardo Slatopolsky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Eduardo Slatopolsky
Chugai Seiyaku Kabushiki Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eduardo Slatopolsky, Chugai Seiyaku Kabushiki Kaisha filed Critical Eduardo Slatopolsky
Publication of CA2013166A1 publication Critical patent/CA2013166A1/fr
Application granted granted Critical
Publication of CA2013166C publication Critical patent/CA2013166C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
CA002013166A 1989-03-28 1990-03-27 Suppression de la synthese et de la secretion de l'hormone parathyroide Expired - Lifetime CA2013166C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US329,606 1989-03-28
US07/329,606 US4948789A (en) 1989-03-28 1989-03-28 Suppression of parathyroid hormone synthesis and secretion

Publications (2)

Publication Number Publication Date
CA2013166A1 true CA2013166A1 (fr) 1990-09-28
CA2013166C CA2013166C (fr) 2001-01-02

Family

ID=23286199

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002013166A Expired - Lifetime CA2013166C (fr) 1989-03-28 1990-03-27 Suppression de la synthese et de la secretion de l'hormone parathyroide

Country Status (15)

Country Link
US (1) US4948789A (fr)
EP (1) EP0390114B1 (fr)
JP (1) JPH0686382B2 (fr)
KR (1) KR0153532B1 (fr)
AT (1) ATE111737T1 (fr)
AU (1) AU618506B2 (fr)
CA (1) CA2013166C (fr)
DE (1) DE69012620T2 (fr)
DK (1) DK0390114T3 (fr)
ES (1) ES2063852T3 (fr)
HK (1) HK66895A (fr)
HU (1) HU211597A9 (fr)
IE (1) IE64949B1 (fr)
IL (1) IL93896A (fr)
ZA (1) ZA902353B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
GB9017890D0 (en) 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
GB9220272D0 (en) * 1992-09-25 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20040043971A1 (en) * 1995-04-03 2004-03-04 Bone Care International, Inc. Method of treating and preventing hyperparathyroidism with active vitamin D analogs
US20020183288A1 (en) * 1995-04-03 2002-12-05 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6376479B1 (en) 1995-04-03 2002-04-23 Bone Care International, Inc. Method for treating and preventing hyperparathyroidism
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
WO2002006218A2 (fr) * 2000-07-18 2002-01-24 Bone Care International, Inc. 1$g(a)hydroxy-vitamine d stabilisée
US20050101574A1 (en) * 2000-08-30 2005-05-12 Seiichi Ishizuka Parathyroid hormone production inhibitors containing vitamin d3 derivatives
US7129230B2 (en) 2001-03-12 2006-10-31 Nestec S.A. Method and product for treating cancer in pets
US20040248859A1 (en) * 2001-07-03 2004-12-09 Michinori Hirata Medicinal compositions for treating secondary parathyroid hyperfunction and remedies for cardiovascular complications in association with treatment for secondary parathyroid hyperfunction
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0184112B1 (fr) * 1984-11-27 1990-05-09 Chugai Seiyaku Kabushiki Kaisha Dérivés de vitamine D et procédé pour les préparer
US4997824A (en) * 1987-07-22 1991-03-05 Teva Pharmaceutical Industries Ltd. Combination of cholecalciferol derivatives for the treatment of renal bone disease

Also Published As

Publication number Publication date
EP0390114B1 (fr) 1994-09-21
HU211597A9 (en) 1995-12-28
EP0390114A2 (fr) 1990-10-03
EP0390114A3 (fr) 1991-10-30
HK66895A (en) 1995-05-12
JPH0686382B2 (ja) 1994-11-02
ES2063852T3 (es) 1995-01-16
US4948789A (en) 1990-08-14
IE64949B1 (en) 1995-09-20
DK0390114T3 (da) 1994-10-17
CA2013166C (fr) 2001-01-02
JPH037231A (ja) 1991-01-14
ATE111737T1 (de) 1994-10-15
AU618506B2 (en) 1991-12-19
KR900013965A (ko) 1990-10-22
DE69012620D1 (de) 1994-10-27
ZA902353B (en) 1990-12-28
DE69012620T2 (de) 1995-03-23
AU5210690A (en) 1990-10-04
KR0153532B1 (ko) 1998-11-16
IE901083L (en) 1990-09-28
IL93896A (en) 1994-10-21

Similar Documents

Publication Publication Date Title
CA2013166A1 (fr) Suppression de la synthese et de la secretion de l'hormone parathyroide
MD960256A (en) Substances, used as sweetening agents and process for preparation thereof
AU8599091A (en) Antimicrobial agents as well as substituted 2-cyclohexan-1-y1-amine derivatives and their preparation
TW221293B (fr)
AU7484887A (en) Method for inhibiting aging
JPS52131540A (en) Phenoxyvaleric acid derivatives and herbicides therefrom
GR3023938T3 (en) 3',5'-ditertbutyl-4'-hydroxyflavones, method for their preparation and pharmaceutical compositions with an antioxidant and antivasoconstricting activity
ES2001341A6 (es) Un procedimiento de producir un derivado de acido guanidinometilbenzoico.
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
HU912649D0 (en) New tricyclic compounds production threreof and anti-microbic preparatives
EG19361A (en) A process for the preparation of piperidine compound having local anaesthetica and analgetic
EP0743308A3 (fr) Composé quinazoléine et composition contre les tumeurs le contenant comme composé actif
ES8301928A1 (es) Un procedimiento para preparar 4-(2-4-dicloro-3-metilbenzoil)-1,3-dimetil-5-fenaciloxipirazol).
AU654300B2 (en) 7-acyl-3-(substituted carbamoyloxy)cephem compounds and process for their preparation
ES8702433A1 (es) Un procedimiento para la preparacion de un compuesto heterociclico sustituido con peptidos.
GB8908700D0 (en) Compounds
ZA949595B (en) Glutaramide derivatives
ES8403911A1 (es) Procedimiento de preparacion de mononitratos de 1.4,3.6- dianhidro-hexito sustituidos en 2-0 y 5-0
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
GB2039739A (en) Medicament against glaucoma
HU9600606D0 (en) Process for the preparation of indolizine derivatives
DE3160851D1 (en) Lidocaine derivative and therapeutic compositions which contain it as their active principle
HUT58471A (en) Herbicidal composition comprising (sulfamidosulfonyl)-urea derivatives as active ingredient and process for producing the active ingredients
UA19166A1 (uk) Гербіцидhа композиція

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry